Xenazine

Showing 2 posts of 2 posts found.

Lundbeck sales slide as generic competition bites

November 6, 2014
Sales and Marketing Ebixa, Lundbeck, Q3, Xenazine, generic, onfi, sabril

Lundbeck’s sales fell dramatically in the third quarter of 2014 as it struggles with expiring patents, although several of its …

Lundbeck issues Lexapro patent warning

November 3, 2010
Sales and Marketing Azilect, Cipralex, Forest Laboratories, Lexapro, Lundbeck, Xenazine

Neurological disorder specialist Lundbeck has posted a modest growth in revenue for the third quarter, but warned the looming patent …

The Gateway to Local Adoption Series

Latest content